UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~March~~December 31, ~~2020~~2021

CAMPBELL STRATEGIC ALLOCATION FUND, L.P.

(Exact name of registrant as specified in charter)

Delaware		000-22260		52-1823554
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

	c/o Campbell & Company, LP 2850 Quarry Lake Drive Baltimore, Maryland 21209
	(Address of principal executive offices, including zip code)

	(410) 413-2600
	(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 85.0102 ~~Other Events.~~

InPer ~~response~~the tosuccession ~~the~~plan ~~COVID-19~~that ~~outbreak~~was initiated in 2019, toeffective ~~protect~~January ~~the~~3, ~~health~~2022 ofKevin ~~Campbell’s~~D. ~~employees~~Cole ~~and~~has ~~the~~been ~~citizens~~named ofChief ~~our~~Executive ~~community,~~Officer ~~all~~while ~~Campbell~~also retaining ~~employees~~his ~~have~~responsibilities ~~transitioned~~as toChief ~~working~~Investment ~~from~~Officer ~~home~~of ~~and~~Campbell ~~will continue~~& toCompany, doLP, sothe ~~until~~Fund’s ~~further~~general ~~notice~~partner. ~~While~~G. weWilliam ~~are~~Andrews, ~~operating~~Campbell ~~from~~& ~~home~~Company’s ~~due~~former CEO, is relocating with his family to ~~our~~his ~~technology~~native ~~framework~~New ~~and~~Zealand. Mr. Andrews ~~systematic~~will ~~investment~~remain ~~structure,~~with ~~our~~Campbell ~~Baltimore~~as ~~office~~a ~~remains~~Managing ~~open~~Director ~~for contingency~~through ~~purposes~~June 2022 to ensure a smooth transition of his responsibilities.

Effective January 3, 2022 John R. Radle has transitioned from his role as Global Head of Trading to Chief Operating Officer of Campbell & Company, LP, the Fund’s general Partner. Gabriel A. Morris, Campbell & Company’s former COO, will be joining a Baltimore based traditional asset manager. Mr. Morris will remain with Campbell through January 25, 2022 to ensure a smooth transition of his responsibilities.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CAMPBELL STRATEGIC ALLOCATION FUND, L.P.
	By:	Campbell & Company, LP,
		its General Partner
Date: April 3, 2020	By:	/s/ Thomas P. Lloyd
Date: January 6, 2022	By:	/s/ Thomas P. Lloyd
		Thomas P. Lloyd
		General Counsel and Chief Compliance Officer

Filing Compare · CAMPBELL STRATEGIC ALLOCATION FUND LP